The study stratified ME/CFS patients into two groups based on their immunological status and presented three key findings: Reduced C4a levels in ME/CFS patients with immunodeficiencies suggested a subgroup-specific disease pattern impairing innate immunity. The gene discussed is C4A; the disease is immunodeficiency disease.